HomeMedical SpecialtiesDiseasesTesting new ways to screen for loss of sensation in diabetic patients

Testing new ways to screen for loss of sensation in diabetic patients

Published on

A team of clinicians at St. Michael’s Hospital is testing a new way to assess patients for diabetic peripheral neuropathy, a loss of sensation in the feet that can result in an inability to feel pain.

Between 60 and 70 per cent of individuals with diabetes lose sensation in their feet, increasing their risk of foot ulcers, which can lead to infection and leg amputation.

The most common test for neuropathy is the monofilament test, which involves placing an instrument similar to a fishing line on areas of the foot, and asking if the patient feels sensation. But a much simpler test, called the Ipswich Touch Test, could be carried out at no cost, without the use of a special tool.

“This test could be used anywhere by anyone, meaning there would be no reason not to check patients with diabetes for neuropathy,” said Ann-Marie McLaren, a chiropodist in the Wound Care Department, who proposed and developed the study. “We’re looking for a tool that can easily identify people with loss of sensation who are at risk for developing a foot ulcer.”

The Ipswich Touch Test, developed by Dr. Gerry Rayman in the U.K., involves examiners using their index finger to touch the tips of the patients’ first, third and fifth toes on both feet in a particular order. Patients are asked to close their eyes and identify when the toe is touched.

“About 85 per cent of people who get their legs amputated had a diabetic ulcer, which they developed because they couldn’t feel their feet,” said Suzanne Lu, a chiropodist in the Mobility Program. “If we can put into practice a simple assessment tool, that means we could start catching people who have neuropathy earlier on, and prevent these kinds of things from happening.”

The study team trained 16 clinicians to use both the Ipswich Touch Test and the monofilament test on eight diabetic patients at St. Michael’s. The team is trying to validate the Ipswich Touch Test to determine whether it could be used in various clinical settings among different health-care professionals including nurses, chiropodists, occupational therapists, physiotherapists, dieticians and physicians.

“We want to see if we can get agreement between the monofilament and Ipswich Touch tests, and see if the touch test works between different health-care practitioners, across different clinical areas,” said McLaren. “With simple screening methods, early recognition of loss of sensation, education and appropriate referrals, we can prevent patients from developing foot complications and save limbs – that’s the ultimate goal.”

Corinne Ton That works in communications at St. Michael’s Hospital in Toronto.

SIDEBAR

How it works: the Ipswich Touch Test

  • Patients are asked to close their eyes
  • Examiners lightly touch three toes on both feet
  • Toes are touched in a particular sequence using the index finger
  • Patients are asked to indicate if they feel the examiner’s finger on their toes

Latest articles

Optimizing opioid prescriptions after the ED to reduce opioid overdoses, misuse

New research aims to help reduce the quantity of unused prescription opioids after emergency...

Collaborating virtually to improve long-term care

Team-building and face-to-face meetings were limited during the COVID-19 pandemic. However, the long-term care...

Physician Assistants: A solution to Ontario’s primary care crisis

Primary care providers are the backbone of our healthcare system. For patients seeking medical...

Many health-care providers are ill-equipped to recognize pain in abused children

McGill study finds only 13 per cent of those surveyed received training on child...

More like this

Many health-care providers are ill-equipped to recognize pain in abused children

McGill study finds only 13 per cent of those surveyed received training on child...

New technology enhances cardiac care

Humber River Health recognizes that modern challenges are best met with modern solutions, and...

New technology for advancing inclusive, equitable care

An imaging device developed by an Ontario start-up company is being studied at Hamilton...

World-first trial shows benefits of finding, treating undiagnosed asthma and COPD

It’s estimated that 70 per cent of people with asthma or COPD go undiagnosed....

Researchers outline how cells activate to cause fibrosis and organ scarring

New research led by Unity Health Toronto that examines how fibroblast cells in the...

London Health Sciences Centre reduces cancer surgery wait times by 50 per cent

Through several focused strategies and a dedicated team effort, London Health Sciences Centre (LHSC)...